Powered by RND
PodcastsBusinessProactive - Interviews for investors

Proactive - Interviews for investors

Proactive
Proactive - Interviews for investors
Latest episode

Available Episodes

5 of 600
  • Supernova Metals appoints Mason Granger as CEO and pursues increased stake in offshore asset
    Supernova Metals CEO Mason Granger joined Steve Darling from Proactive to discuss has appointment as Chief Executive Officer. Granger brings over two decades of capital markets experience, with a background in portfolio management of public and private oil and gas assets. He is a five-time recipient of the Brendan Wood International TopGun Investment Mind award and has earned a Canadian Lipper Fund Award. Granger is also recognized for his leadership in ESG, sustainability, and energy transition. In conjunction with his appointment, Supernova has entered into a non-binding letter of intent with Orogen Corp. to evaluate the potential acquisition of an additional 36% equity interest in WestOil Limited. WestOil, a private company based in the Republic of Seychelles, holds a 70% operating interest in Block 2712A, offshore Namibia in the highly prospective Orange Basin. Supernova, through its subsidiary NamLith Resources Corp., currently owns a 12.5% interest in WestOil. The proposed transaction would increase the company’s stake to 48.5%. This strategic move positions Supernova to significantly enhance its exposure to one of the world’s most active offshore exploration regions. #proactiveinvestors #supernovametalscorp #cse #supr #NamibiaOil #OilExploration #EnergyInvesting #OffshoreDrilling #OrangeBasin #MasonGranger #OilAndGas #3DSeismic #JuniorExplorers #ResourceStocks
    --------  
    4:05
  • Immunic CMO on Celiac Disease Awareness Month, potential of IMU-856
    Immunic Inc chief medical officer Dr Andreas Muehler talked with Proactive's Stephen Gunnion about new developments in celiac disease research during Celiac Disease Awareness Month. He emphasized the seriousness of the autoimmune condition, noting it is often misdiagnosed due to vague symptoms. “Celiac disease is a really important disease with significant consequences for patients,” Muehler said, citing malnutrition, infertility, and even malignancy risks as complications. The emotional and social toll of the condition, he added, is also substantial, with many patients facing isolation due to dietary restrictions. Muehler discussed Immunic's investigational drug IMU-856, which targets the SIRT-6 protein to regenerate intestinal lining and strengthen gut barrier function. Early results from a Phase 1b trial involving 43 patients indicated improvements across multiple measures: bowel histology, disease symptoms, biomarkers, and micronutrient absorption. At the recent DDW conference, Immunic presented data showing IMU-856's efficacy even in patients with severe intestinal damage. Additionally, the drug's absorption was not hindered by pre-existing gut damage, an encouraging sign for future use. Muehler also noted the drug’s impact on GLP-1 hormone levels, aligning with emerging gastrointestinal treatment trends. Visit Proactive's YouTube channel for more videos, and don't forget to give the video a like, subscribe to the channel and enable notifications for future content. #CeliacDisease #ImmunicInc #IMU856 #AutoimmuneDisorders #GutHealth #BiotechNews #DDW2025 #CeliacTreatment #Epigenetics #GLP1 #MedicalResearch
    --------  
    13:53
  • Sona Nanotech and BioVaxys partner to develop next-generation cancer therapies
    Sona Nanotech CEO David Regan joined Steve Darling from Proactive to announce a groundbreaking Research Agreement with BioVaxys Technology Corp. aimed at developing a novel class of cancer therapeutics. The collaboration unites two innovative technologies: BioVaxys’ Immune Educating Platform (DPX) and Sona’s Targeted Hyperthermia Therapy (THT), powered by proprietary gold nanorod technology. Sona’s THT is an advanced photothermal cancer therapy that uses near-infrared light to generate localized heat within solid tumors. This thermal energy is delivered through Sona’s biocompatible gold nanorods, which not only destroy tumor cells but also stimulate a strong immune response—a crucial factor in combating cancer recurrence. The research will explore how BioVaxys’ DPX platform, known for priming the innate immune system, can further enhance this immune response when used in tandem with THT. “The potential synergy between these two technologies could significantly accelerate the immune system’s ability to recognize and attack tumors,” said Regan. One area of focus is the use of DPX to deliver tumor-specific neoantigens—unique proteins that emerge after cancer cell mutations and are absent from healthy tissues. Since THT can induce these mutations and neoantigen expression, pairing it with DPX could dramatically improve immune system targeting and treatment efficacy. Essentially, THT triggers changes in tumor cells, and DPX packages those changes for the immune system to attack. The research initiative is supported by the Giacomantonio Immuno-Oncology Research Group, which will fund the preclinical studies. Both companies will contribute their core technologies to the collaboration. Any new therapeutic candidate developed will be jointly owned and prosecuted by BioVaxys and Sona, with a commercialization agreement planned ahead of a potential Phase 1 clinical trial. #proactiveinvestors #sonananotechinc #cse #sona #otcqb #snanf #CancerResearch #MelanomaTreatment #BioVaxys #DPXTechnology #ClinicalTrials #TargetedTherapy #GoldNanorods #OncologyInnovation #ProactiveInvestors
    --------  
    4:41
  • High-grade copper hits boost FireFly Metals’ Green Bay plan
    FireFly Metals Ltd managing director Steve Parsons talked with Proactive about the company’s ongoing drilling success at the Green Bay Copper-Gold Project in Newfoundland, Canada. FireFly has reported strong extensional drilling results that intersect mineralisation more than 200 metres beyond the current Mineral Resource Estimate. The Green Bay Project currently hosts a Measured and Indicated Mineral Resource of 24.4 million tonnes at 1.9% copper equivalent (CuEq), with an additional 34.5 million tonnes at 2.0% CuEq classified as Inferred. Drilling is targeting growth through multiple fronts, including a 35,000-metre resource extension program and a further 35,000 metres for infill drilling to convert Inferred resources. Significant new intercepts include 25.8 metres at 5.1% CuEq and 12.4 metres at 6.8% CuEq. Drilling from the 805 Level continues to deliver high-grade hits across both VMS and Footwall Zone (FWZ) styles of mineralisation. Underground drilling continues with five rigs active, and a sixth underground rig is arriving in late May. A Down Hole Electromagnetic (DHEM) anomaly over 700 metres beyond current drill extents is also being tested, presenting further exploration potential. “We are about to add a seventh rig because we have so many opportunities to pursue,” Parsons said. “There are very few projects which could justify such an aggressive drilling campaign.” Visit Proactive’s YouTube channel for more videos, and don’t forget to give the video a like, subscribe to the channel, and enable notifications for future content. #FireFlyMetals #CopperExploration #GoldMining #GreenBayProject #NewfoundlandMining #DrillingResults #MineralResource #MingMine #MiningUpdates #ResourceExpansion #VMS #ExplorationNews #JuniorMining
    --------  
    3:12
  • Bitcoin flirts with $100K amid de-dollarisation trends, corporate demand
    Bitwise Asset Management European head Bradley Duke talked with Proactive's Stephen Gunnion about the resurgence of Bitcoin to the $100,000 mark and the forces driving its momentum. Duke described the current environment as a "really bullish moment for Bitcoin", noting that the price has recovered steadily from recent lows of around $75,000. He attributed the surge to macroeconomic forces, particularly rising inflation expectations and growing scepticism toward the US dollar, describing the situation as part of a broader trend of “de-dollarisation”. He explained that aggressive US tariff policies are fuelling inflation expectations globally, pushing investors to consider alternative assets. Duke said, “We’ve seen that there’s a correlation to an increase in the price of Bitcoin if there’s a high expectation of inflation.” Duke also pointed to expanding corporate adoption of Bitcoin as a significant new development. He revealed that listed corporations had acquired over 101,000 bitcoins so far in 2025 — more than double the total new supply of Bitcoin this year. He noted that even US states have started to hold Bitcoin in their treasuries as part of strategic reserves, suggesting the shift from traditional assets to Bitcoin is accelerating. Visit Proactive's YouTube channel for more videos, and don't forget to give the video a like, subscribe to the channel, and enable notifications for future content. #Bitcoin #Cryptocurrency #DigitalAssets #BradleyDuke #Bitwise #BitcoinPrice #CorporateTreasuries #DeDollarization #InflationHedge #CryptoMarkets #ProactiveInvestors
    --------  
    7:30

More Business podcasts

About Proactive - Interviews for investors

Welcome to the Proactive podcast channel – the destination for breaking news on growth companies and up to the minute market coverage. Here we plug you into what’s new and exciting in the world of business.
Podcast website

Listen to Proactive - Interviews for investors, The Diary Of A CEO with Steven Bartlett and many other podcasts from around the world with the radio.net app

Get the free radio.net app

  • Stations and podcasts to bookmark
  • Stream via Wi-Fi or Bluetooth
  • Supports Carplay & Android Auto
  • Many other app features

Proactive - Interviews for investors: Podcasts in Family

Social
v7.17.1 | © 2007-2025 radio.de GmbH
Generated: 5/9/2025 - 5:53:39 PM